- Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysisIoannis, Farmakis; Ioannis, Doundoulakis; Areti, Pagiantza; Stefanos, Zafeiropoulos; Christina, Antza; Haralambos, Karvounis; George, GiannakoulasJournal of Cardiovascular Pharmacology, 2021, 77(3): 397-407.
- EFFICACY AND SAFETY OF EVOLOCUMAB IN CHINESE PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA: PRIMARY RESULTS OF THE HUA TUO _ CLINICAL TRIALTan, H.; Li, W.; Huang, Z.; Han, Y.; Huang, X.; Li, D.; Xing, X.; Monsalvo, M. L.; Wu, Y.; Mao, J.; Xin, L.; Chen, J.Annual Meeting of the European-Astronomical-Society (EAS), Valencia, SPAIN, 2022-06-27 To 2022.
- The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosisEliane Parra; Natália Panzoldo; Denise Kaplan; Helena Coutinho de Oliveira; José dos Santos; Luiz Sérgio de Carvalho; Andrei Sposito; Magnus Gidlund; Ruy Nakamura; Vanessa de Souza Zago; Edna Nakandakare; Eder Carlos Quintão; Eliana de FariaLipids in Health and Disease, 2012, 11(1): 130.
会议论文
A systematic review and meta-analysis of randomized controlled trials on the impact of ezetimibe on carotid intima-media thickness
11阅读
